共 32 条
[1]
Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin. 71 209-249
[2]
Alexander M(2017)Lung cancer prognostic index: A risk score to predict overall survival after the diagnosis of non-small-cell lung cancer Br. J. Cancer 117 744-751
[3]
Dienstmann R(2017)Prediction of overall survival in stage II and III colon cancer beyond TNM system: A retrospective, pooled biomarker study Ann. Oncol. 28 1023-1031
[4]
Vargas AJ(2016)Biomarker development in the precision medicine era: Lung cancer as a case study Nat. Rev. Cancer 16 525-537
[5]
Harris CC(2017)Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13 BMJ 2017 359 j4530-182
[6]
Davis C(2010)TP53 mutations in human cancers: origins, consequences, and clinical use Cold Spring Harb. Perspect. Biol. 2 a001008-4689
[7]
Olivier M(2015)PTEN: multiple functions in human malignant tumors Front Oncol. 5 24-862
[8]
Hollstein M(2002)Cancer susceptibility and the functions of BRCA1 and BRCA2 Cell 108 171-312
[9]
Hainaut P(1989)ras oncogenes in human cancer: Areview [published correction appears in Cancer Res 1990 Feb 15;50(4):1352] Cancer Res. 49 4682-489
[10]
Milella M(2011)BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer Br. J. Cancer 104 856-1011